Morgan Stanley’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-565,941
| Closed | -$85.6M | – | 8204 |
|
2022
Q3 | $85.6M | Buy |
565,941
+375,508
| +197% | +$56.8M | 0.01% | 985 |
|
2022
Q2 | $27.7M | Buy |
190,433
+87,881
| +86% | +$12.8M | ﹤0.01% | 1928 |
|
2022
Q1 | $12.2M | Buy |
102,552
+19,949
| +24% | +$2.37M | ﹤0.01% | 2679 |
|
2021
Q4 | $11.4M | Buy |
82,603
+40,245
| +95% | +$5.55M | ﹤0.01% | 2808 |
|
2021
Q3 | $5.88M | Sell |
42,358
-11,311
| -21% | -$1.57M | ﹤0.01% | 3503 |
|
2021
Q2 | $5.21M | Buy |
53,669
+12,560
| +31% | +$1.22M | ﹤0.01% | 3738 |
|
2021
Q1 | $2.81M | Sell |
41,109
-100,556
| -71% | -$6.87M | ﹤0.01% | 3987 |
|
2020
Q4 | $12.1M | Buy |
141,665
+91,018
| +180% | +$7.8M | ﹤0.01% | 2302 |
|
2020
Q3 | $3.29M | Sell |
50,647
-30,819
| -38% | -$2M | ﹤0.01% | 3148 |
|
2020
Q2 | $5.96M | Buy |
81,466
+24,410
| +43% | +$1.78M | ﹤0.01% | 2485 |
|
2020
Q1 | $1.94M | Sell |
57,056
-18,605
| -25% | -$633K | ﹤0.01% | 3396 |
|
2019
Q4 | $4.12M | Buy |
75,661
+681
| +0.9% | +$37.1K | ﹤0.01% | 3408 |
|
2019
Q3 | $3.13M | Sell |
74,980
-18,882
| -20% | -$788K | ﹤0.01% | 3372 |
|
2019
Q2 | $4.11M | Buy |
93,862
+14,539
| +18% | +$637K | ﹤0.01% | 3115 |
|
2019
Q1 | $4.08M | Buy |
79,323
+32,617
| +70% | +$1.68M | ﹤0.01% | 2900 |
|
2018
Q4 | $1.73M | Sell |
46,706
-55,648
| -54% | -$2.06M | ﹤0.01% | 3885 |
|
2018
Q3 | $3.84M | Sell |
102,354
-141,996
| -58% | -$5.33M | ﹤0.01% | 3461 |
|
2018
Q2 | $9.66M | Buy |
244,350
+164,054
| +204% | +$6.48M | ﹤0.01% | 2412 |
|
2018
Q1 | $2.07M | Buy |
80,296
+49,179
| +158% | +$1.27M | ﹤0.01% | 3983 |
|
2017
Q4 | $839K | Buy |
31,117
+4,173
| +15% | +$113K | ﹤0.01% | 4666 |
|
2017
Q3 | $1.01M | Buy |
26,944
+15,382
| +133% | +$575K | ﹤0.01% | 4424 |
|
2017
Q2 | $289K | Buy |
+11,562
| New | +$289K | ﹤0.01% | 5131 |
|